Prim, N.
642  results:
Search for persons X
?
1

Pharmacokinetics/pharmacodynamics and therapeutic drug moni..:

Fresan, D ; Luque, S ; Benítez-Cano, A...
Journal of Antimicrobial Chemotherapy.  78 (2023)  3 - p. 678-683 , 2023
 
?
2

Macrolide resistance in Mycoplasma genitalium in Catalonia,..:

Lucena Nemirosky, J ; Espelt, R ; López Grado, E...
Journal of Antimicrobial Chemotherapy.  76 (2021)  10 - p. 2702-2707 , 2021
 
?
3

Corrigendum to "Linezolid vs glycopeptides in the treatment..:

Echeverria-Esnal, D. ; Sorli, L. ; Prim, N....
International Journal of Antimicrobial Agents.  58 (2021)  6 - p. 106455 , 2021
 
?
4

Linezolid vs glycopeptides in the treatment of glycopeptide..:

Echeverria-Esnal, D. ; Sorli, L. ; Prim, N....
International Journal of Antimicrobial Agents.  54 (2019)  5 - p. 572-578 , 2019
 
?
5

Predictors of outcome in patients with severe sepsis or sep..:

Russo, A. ; Falcone, M. ; Gutiérrez-Gutiérrez, B....
International Journal of Antimicrobial Agents.  52 (2018)  5 - p. 577-585 , 2018
 
?
6

Bacillus species pseudo-outbreak: construction works and co..:

Boix-Palop, L. ; Nicolás, C. ; Xercavins, M....
Journal of Hospital Infection.  95 (2017)  1 - p. 118-122 , 2017
 
?
7

L'afatinib (BIBW 2992):

Prim, N. ; Fore, M. ; Mennecier, B.
Revue de Pneumologie Clinique.  70 (2014)  5 - p. 279-285 , 2014
 
?
 
?
 
?
11

Biochemical studies on cloned Bacillus sp. BP-7 phenolic ac..:

Prim, N. ; Pastor, F. I. J. ; Diaz, P.
Applied Microbiology and Biotechnology.  63 (2003)  1 - p. 51-56 , 2003
 
1-15